Citations

Showing 10 of 108104 citations.

Practical guidance for telemedicine use in neuro-oncology
Dunbar, Erin, Gan, Hui , Kurz, Sylvia C. , Mandel, Jacob , Mohile, Nimish, Nevel, Kathryn , Taylor, Jennie , Ullrich, Nicole J. , Welch, Mary , Wasilewski, Andrea , Mrugala, Maciej , Kurz, Sylvia , Strowd, Roy E. , Jordan, Justin T.

Mayo Clinic

Neuro-Oncology Practice | January 17, 2022 | Volume: 9 | Issue: 2 | Pages: 91-104

10.1093/nop/npac002 | PMID 35371525 Get It

AbstractWhile the COVID-19 pandemic has catalyzed the expansion of telemedicine into nearly every specialty of medicine, few articles have summarized current practices and recommendations for integrating virtual care in the practice of neuro-oncology. This article identifies current telemedicine practice, provides practical guidance for conducting telemedicine visits, and generates recommendations for integrating virtual care into neuro-oncology practice. Practical aspects of telemedicine are summarized including when to use and not use telemedicine, how to conduct a virtual visit, who to include in the virtual encounter, unique aspects of telehealth in neuro-oncology, and emerging innovations.
Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications
Fonkoua, Lionel Aurelien Kankeu , Usón, Pedro Luiz Serrano , Mody, Kabir , Roberts, Lewis R. , Kankeu Fonkoua, Lionel A, Serrano Uson Junior, Pedro Luiz, Roberts, Lewis R , Uson, Pedro L S , Mahipal, Amit , Borad, Mitesh J.

Mayo Clinic

Expert Opinion on Therapeutic Targets | January 17, 2022 | Volume: 26 | Issue: 1 | Pages: 79-92

10.1080/14728222.2022.2029412 | PMID 35034558 Get It

Current salvage therapies in Hodgkin lymphoma
Chohan, Karan, Ansell, Stephen M., Chohan, Karan , Chohan, Karan L , Chohan, Karan, Ansell, Stephen M.

Mayo Clinic

Leukemia & Lymphoma | January 17, 2022 | Volume: 63 | Issue: 6 | Pages: 1267-1280

10.1080/10428194.2021.2024819 | PMID 35037568 Get It

More Than Skin Deep: Dermatologic Conditions in Athletes
Costa, Lorena M.C., Clapp, Adrianna D.M. , Presutti, R. John , Sluzevich, Jason C. , Clapp, Adrianna D, Presutti, Richard J , Sluzevich, Jason C , Clapp, Adrianna , Pujalte, George G.A.

Mayo Clinic

Sports Health: A Multidisciplinary Approach | January 17, 2022 | Volume: 15 | Issue: 1 | Pages: 74-85

10.1177/19417381211065026 | PMID 35034516 Get It

Context: Athletes are a unique group of patients whose activities, particularly in high-contact sports such as wrestling and football, place them at high risk of developing skin conditions. The correct diagnosis of sports dermatoses requires familiarity with their clinical characteristics. It is critical that primary care physicians recognize the most common skin disorders to provide prompt treatment and prevent transmission. Evidence Acquisition: The Mayo Clinic library obtained articles from 2012 onward related to dermatologic conditions in athletes. Study Design: Review article. Level of Evidence: Level 3. Results: Dermatologic diseases in athletes are often infectious and contagious due to close-contact sports environments. Sports-related dermatoses include bacterial infections, such as impetigo, ecthyma, folliculitis, abscesses, furuncles, carbuncles, erysipelas, and cellulitis; fungal infections, such as tinea and intertrigo; viral infections, such as herpes, verrucae, and molluscum contagiosum; and noninfectious conditions, such as acne, blisters, and contact dermatitis. Conclusion: This article aims to address the manifestations of the most common cutaneous diseases in athletes on the first primary care visit. It discusses the appropriate tests and most recent evidence-based treatments for each ailment. It also addresses return-to-play recommendations related to the guidelines and regulations of selected sports organizations in the United States. Strength of Recommendation Taxonomy (SORT): C.
Seasonal Accumulated Workloads in Collegiate Women’s Soccer: A Comparison of Starters and Reserves
Jagim, Andrew R. , Askow, Andrew T. , Carvalho, Victoria , Murphy, Jason, Luedke, Joel, Erickson, Jacob L. , Luedke, Joel A, Jagim, Andrew R , Askow, Andrew T

Mayo Clinic

Journal of Functional Morphology and Kinesiology | January 16, 2022 | Volume: 7 | Issue: 1 | Pages: 11

10.3390/jfmk7010011 | PMID 35076561 Get It

Research quantifying the unique workload demands of starters and reserves in training and match settings throughout a season in collegiate soccer is limited. Purpose: The purpose of the current study is to compare accumulated workloads between starters and reserves in collegiate soccer. Methods: Twenty-two NCAA Division III female soccer athletes (height: 1.67 ± 0.05 m; body mass: 65.42 ± 6.33 kg; fat-free mass: 48.99 ± 3.81 kg; body fat %: 25.22 ± 4.78%) were equipped with wearable global positioning systems with on-board inertial sensors, which assessed a proprietary training load metric and distance covered for each practice and 22 matches throughout an entire season. Nine players were classified as starters (S), defined as those playing >50% of playing time throughout the entire season. The remaining 17 were reserves (R). Goalkeepers were excluded. A one-way ANOVA was used to determine the extent of differences in accumulated training load throughout the season by player status. Results: Accumulated training load and total distance covered for starters were greater than reserves ((S: 9431 ± 1471 vs. R: 6310 ± 2263 AU; p < 0.001) and (S: 401.7 ± 31.9 vs. R: 272.9 ± 51.4 km; p < 0.001), respectively) throughout the season. Conclusions: Starters covered a much greater distance throughout the season, resulting in almost double the training load compared to reserves. It is unknown if the high workloads experienced by starters or the low workloads of the reserves is more problematic. Managing player workloads in soccer may require attention to address potential imbalances that emerge between starters and reserves throughout a season.
Implication of Adult Hippocampal Neurogenesis in Alzheimer’s Disease and Potential Therapeutic Approaches
Essa, Hesham, Peyton, Lee, Hasan, Whidul , León, Brandon Emanuel, Choi, Doo-Sup, Peyton, Lee , Essa, Hesham , Hasan, Whidul , León, Brandon Emanuel, Choi, Doo-Sup

Mayo Clinic

Cells | January 16, 2022 | Volume: 11 | Issue: 2 | Pages: 286

10.3390/cells11020286 | PMID 35053402 Get It

Alzheimer’s disease is the most common neurodegenerative disease, affecting more than 6 million US citizens and representing the most prevalent cause for dementia. Neurogenesis has been repeatedly reported to be impaired in AD mouse models, but the reason for this impairment remains unclear. Several key factors play a crucial role in AD including Aβ accumulation, intracellular neurofibrillary tangles accumulation, and neuronal loss (specifically in the dentate gyrus of the hippocampus). Neurofibrillary tangles have been long associated with the neuronal loss in the dentate gyrus. Of note, Aβ accumulation plays an important role in the impairment of neurogenesis, but recent studies started to shed a light on the role of APP gene expression on the neurogenesis process. In this review, we will discuss the recent approaches to neurogenesis in Alzheimer disease and update the development of therapeutic methods.
How to manage traumatic brain injury without invasive monitoring?
Godoy, Daniel A., Rabinstein, Alejandro A., Godoy, Daniel A., Rabinstein, Alejandro A.

Mayo Clinic

Current Opinion in Critical Care | January 16, 2022 | Volume: 28 | Issue: 2 | Pages: 111-122

10.1097/mcc.0000000000000914 | PMID 35034077 Get It

Purpose of review Severe traumatic brain injury (TBI) is an extremely serious health problem, especially in low–middle income countries (LMICs). The prevalence of severe TBI continues to increase in LMICs. Major limitations in the chain of care for TBI patients are common in LMICs including suboptimal or nonexistent prehospital care, overburdened emergency services, lack of trained human resources and limited availability of ICUs. Basic neuromonitoring, such as intracranial pressure, are unavailable or underutilized and advanced techniques are not available. Recent findings Attention to fundamental principles of TBI care in LMICs, including early categorization, prevention and treatment of secondary insults, use of low-cost technology for evaluation of intracranial bleeding and neuromonitoring, and emphasis on education of human resources and multidisciplinary work, are particularly important in LMICs. Institutional collaborations between high-income and LMICs have developed evidence focused on available resources. Accordingly, an expert group have proposed consensus recommendations for centers without availability of invasive brain monitoring. Summary Severe TBI is very prevalent in LMIC and neuromonitoring is often not available in these environments. When intracranial pressure monitors are not available, careful attention to changes on clinical examination, serial imaging and noninvasive monitoring techniques can help recognize intracranial hypertension and effectively guide treatment decisions.
Validated 5 – Point photonumeric scales for the assessment of hand atrophy
Pavicic, Tatjana , Pooth, Rainer, Prinz, Valentina, Cajkovsky, Mia, Hernandez, Claudia A, Mueller, Daniel S., Sattler, Sonja , Klepetko, Heike , Kerscher, Martina , Fabi, Sabrina G. , Frank, Konstantin , Day, Doris , Cotofana, Sebastian , Frank, Konstantin , Green, Jeremy B. , Mueller, Daniel S., Suwanchinda, Atchima , Cotofana, Sebastian

Mayo Clinic

Journal of Cosmetic Dermatology | January 16, 2022 | Volume: 21 | Issue: 3 | Pages: 933-939

10.1111/jocd.14776 | PMID 35034418 Get It

AbstractObjectiveQuantifying the degree of dorsal hand atrophy is a challenging endeavor, but often necessary, in both the clinical and the research setting. The aim of this investigation was to create and consecutively validate a 5‐point photonumeric scale for assessment of dorsal hand atrophy.Material and MethodsA medical team created a novel 5‐point photonumeric scale. Twelve international raters were involved in the digital validation, while five raters performed a live validation.ResultsFor the digital validation of the Croma Hand Atrophy Assessment Scale, a total of 72 subjects (58 females, 14 males) with a mean age of 43.0 ± 14.4 years [18–73 years] were assessed. For the live validation, 88 subjects (73 females, 15 males) with a mean age of 45.0 ± 14.1 years [20–73 years] were rated. The results revealed almost perfect intra‐rater (ICC: 0.90 [95% CI: 0.88–0.92]) and inter‐rater agreements (ICC: 0.85 [95% CI: 0.81–0.89] and 0.86 [95% CI:0.82–0.89]) in the digital validation and substantial intra‐rater (ICC: 0.79 [95% CI: 0.75–0.82]) and inter‐rater agreements (ICC: 0.75 [95% CI: 0.68–0.81] and ICC: 0.67 [95% CI: 0.54–0.77]) in the live validation.ConclusionThe created scale to assess dorsal hand atrophy has been shown to provide substantial‐to‐almost perfect agreement in the digital and live validation cycles and reached comparable intra‐rater and inter‐rater agreement to already published and validated scales. It is expected that the created scale will help physicians and researchers in the assessment of hand atrophy in the clinical and research setting in the future.
Pazopanib in Patients with Osteosarcoma Metastatic to the Lung: Phase 2 Study Results and the Lessons for Tumor Measurement
Frankel, Paul , Ruel, Chris , Uche, An, Choy, Edwin , Okuno, Scott H. , Somiah, Neeta, Chow, Warren , Ruel, Christopher , Okuno, Scott , Somaiah, Neeta , Chow, Warren A , Choy, Edwin

Mayo Clinic

Journal of Oncology | January 16, 2022 | Volume: 2022 | Issue: No issue available | Pages: 1-9

10.1155/2022/3691025 | PMID 35075361 Get It

Background. This single-arm, multicenter, phase 2 study evaluated the safety and antitumor activity of pazopanib in patients with unresectable, pulmonary metastatic osteosarcoma. Patients and Methods. Patients with pulmonary metastatic osteosarcoma unresponsive to chemotherapy were eligible. Patients who received prior tyrosine kinase inhibitor therapy were excluded. Pazopanib at 800 mg once daily was administered for 28-day cycles. Tumor responses were evaluated by local radiology assessment 1 month prior to and after initiation of treatment to calculate tumor doubling time and after every even numbered cycle. The primary endpoints were progression-free survival at 4 months, concomitant with a demonstrated 30% increase in tumor doubling time relative to the pretreatment growth rate. Results. 12 patients (7 female) were enrolled. The study was terminated prematurely due to withdrawal of financial support by the sponsor. 8 subjects were eligible for the primary analysis, whereas 4 patients were in a predefined exploratory “slow-growing” cohort. In the “fast-growing” cohort, 3 of the 8 patients (37.5%) eligible for first-stage analysis were deemed “success” by the preplanned criteria, adequate to proceed to second-stage accrual. In addition, 1 of the 4 patients in the “slow-growing” cohort experienced a partial remission. Grade 1-2 diarrhea was the most common adverse event, and grade 3 events were infrequent. Conclusion. This study illustrates a novel method of demonstrating positive drug activity in osteosarcoma by increasing tumor doubling time, and this is further supported by a partial response in a patient with “slow-growing” disease. This trial is registered with NCT01759303.
AAPM Task Group Report 272: Comprehensive acceptance testing and evaluation of fluoroscopy imaging systems
Goode, Allen R. , Corwin, Frank, Fisher, Ryan , Balter, Stephen , Wunderle, Kevin , Schueler, Beth A. , Kim, Don‐Soo , Zhou, Yifang , Jenkins, Peter , Mahmood, Usman , Lin, Teh, Zhao, Hui , Park, Mi‐Ae , Trianni, Annalisa , Lendle, Markus, Kuhls‐Gilcrist, Andrew, Jans, J. C., Desponds, L. , Banasiak, Gene, Backes, Steve, Snyder, Angela, Lu, Minghui , Gonzalez, Scott, Lin, Pei‐Jan Paul , Zhang, Jie , Jenkins, Peter A., Snyder, Carl

Mayo Clinic

Medical Physics | January 15, 2022 | Volume: 49 | Issue: 4 | Pages: No page available

10.1002/mp.15429 | PMID 35032394 Get It

AbstractModern fluoroscopes used for image guidance have become quite complex. Adding to this complexity are the many regulatory and accreditation requirements that must be fulfilled during acceptance testing of a new unit. Further, some of these acceptance tests have pass/fail criteria, whereas others do not, making acceptance testing a subjective and time‐consuming task. The AAPM Task Group 272 Report spells out the details of tests that are required and gives visibility to some of the tests that while not yet required are recommended as good practice. The organization of the report begins with the most complicated fluoroscopes used in interventional radiology or cardiology and continues with general fluoroscopy and mobile C‐arms. Finally, the appendices of the report provide useful information, an example report form and topics that needed their own section due to the level of detail.